TYRO3 and malignant colon neoplasm: Furthermore, in a recent study using TYRO3 antibodies for the treatment of colon cancer, TYRO3 inhibited epithelial-mesenchymal transition (EMT) in colon cancer cells (Chien et al., 2016).